Stanley H. Appel
Department of Neurology
Welcome from the Neurology Chair
Welcome to the Houston Methodist Stanley H. Appel Department of Neurology!
Our department firmly upholds three traditional academic missions – patient care, teaching, and research. Each of the three missions now has greater potential in the decades to come.
Located in the world-renowned Texas Medical Center with neighbors of Houston Museum District, Rice University, Baylor College of Medicine, UT Health, Texas A&M and others, Houston Methodist Hospital along with its 7 satellite hospitals serve millions of people throughout the metropolitan of Houston. Our department, as a part of Houston Methodist Neurological Institute, undergoes a major expansion. In addition to the existing clinical services in a variety of subspecialties, such as stroke, epilepsy, movement disorders, neuromuscular diseases, dementia, neuro-oncology and clinical electrophysiology, our department aims to set up multi-disciplinary clinics that are highly specialized and dedicated to specific neurological diseases. We are determined to bring the highest quality of care to our patients.
Along with our clinical missions, the department is strongly motivated to become a platform for innovation. We believe that neurology training can be more effectively delivered by new education tools, such as interactive online curriculum and project design with specific subject driven solutions for neurological diseases, to achieve not only a clear understanding of neurological diseases but also foster creativity and critical thinking. These are essential skills for our trainees to stay competitive and become valuable contributors in neurological sciences in the era of revolutionary digital technology.
We believe that research is the best driving force to produce highest quality care for our patients. Our department actively pursues new technologies to improve functional measurements that are applicable to a variety of neurological diseases, and we are committed to developing new therapeutic approaches for these diseases. This effort is strongly strengthened by talents and collaborative opportunities enriched in the Texas Medical Center. In addition, we make every effort to create an optimal research environment for our faculties to gain deep understandings of the pathogenesis of neurological diseases and translate their discoveries to bedside uses.
Our expertise and services have been recognized both locally and nationally by our peers. In 2022, the U.S. News & World Report ranked this neurology department the 15th in the nation.
This is an exciting time to work in the field of Neurology as the advancement of biomedical sciences and digital technology are redefining what it means to be a neurologist. Cutting edge technologies are rapidly revising our knowledge and therapies against neurological diseases, and we are particularly enthusiastic about the opportunities at Houston Methodist Hospital and Houston Methodist Research Institute. Our vision coincides with the Houston Methodist Neurological Institute development that are spearheaded by the institution leadership and faculty members. These efforts are occurring simultaneously with the economical and technological boom of Houston, which will have a profoundly positive impact on the overall wellbeing of the institution and our department.
If you share in our enthusiasm, please contact us and become a supporter of our academic missions. We also welcome any talented Residents, Fellows, Neurologists and Physician Scientists who would be interested in joining us!
Jun Li, MD, PhD, FANA, FAAN
Neurology CMTA CENTER OF EXCELLENCE
Friday, Sep 15, 2023 - Sat, Sep 16, 2023 Houston Methodist Research Institute
Course Directors: Drs. Gadhia and Eugene Lai
Friday, Oct 6, 2023
Houston Methodist Research Institute
Course Directors: Drs. Shroff and Greene
- A Contemporary Review of Epidemiology, Risk Factors, Etiology, and Outcomes of Premature Stroke. Potter TBH, Tannous J, Vahidy FS. Curr Atheroscler Rep. 2022 Dec;24(12):939-948. doi: 10.1007/s11883-022-01067-x. Epub 2022 Nov 14.
- Temporal Dynamics of the Scale for the Assessment and Rating of Ataxia in Spinocerebellar Ataxias. Moulaire P, Poulet PE, Petit E, Klockgether T, Durr A, Ashisawa T, Tezenas du Montcel S; READISCA Consortium. Mov Disord. 2022 Oct 23. doi: 10.1002/mds.29255. Online ahead of print. PMID: 36273394
- Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3 Chandrasekaran J, Petit E, Park YW, du Montcel ST, Joers JM, Deelchand DK, Považan M, Banan G, Valabregue R, Ehses P, Faber J, Coupé P, Onyike CU, Barker PB, Schmahmann JD, Ratai EM, Subramony SH, Mareci TH, Bushara KO, Paulson H, Durr A, Klockgether T, Ashizawa T, Lenglet C, Öz G; READISCA Consortium. Ann Neurol. 2022 Dec 13. doi: 10.1002/ana.26573. Online ahead of print. PMID: 36511514
- Sensory and corticospinal signs before ataxia onset in SCA1 and SCA3: the READISCA study Sophie Tezenas du Montcel, Emilien Petit, Titi Olubajo, Jennifer Faber, Pauline Lallemant, Khalaf Bushara, Susan Perlman, S. H. Subramony, David Morgan, Brianna Jackman, Henry Paulson, Gülin Öz, Thomas Klockgether, Alexandra Durr, Tetsuo Ashizawa, and READISCA Consortium Collaborators. Sensory and corticospinal signs before ataxia onset in SCA1 and SCA3: the READISCA study. Neurology (accepted).
- Delirium Leads to Poor In‐Hospital and 90‐Day Outcomes Among Patients with Acute Ischemic Stroke with and Without Intravenous Thrombolysis or Intraarterial Therapy. Alan P. Pan, Kathryn Agarwal, George E. Taffet, Stephen L. Jones, Thomas Potter, Abdulaziz Bako, Jonika Tannous, Charles D. McCane, Wamda O. Ahmed, Tanu Garg, Rajan Gadhia, Vivek Misra, John Volpi, David Chiu and Farhaan S. Vahidy Originally published 5 Jul 2022 https://doi.org/10.1161/SVIN.122.000338Stroke: Vascular and Interventional Neurology. 2022;2: e000338
Neurology Latest News and Research
NEUROLOGY LECTURE SERIES
The current HMNI Lecture Series can now be viewed on our YouTube Channel.
NI YouTube Channel @neurologicalinstitute
- Dr. Jon Toledo was invited to speak at the LBDA Industry Advisory meeting on December 6th discussing “Impact of co-pathologies in DLB clinical trial design.”
- Dr. Ali Faridar and Dr. Belen Pascual received the R01 Award for $1,961,007. Title: ”Central and peripheral immune cross-talk in Alzheimer’s disease and their modulation
by novel immunotherapy.” Co-PIs: Dr. Joseph Masdeu and Dr. Stanley Appel
- Dr. Joseph Masdeu participated in the December 2nd Board of Directors meeting of the United Council for Neurological Subspecialties in Minneapolis, MN
6560 Fannin St.
Scurlock Tower, 8th Floor
Houston, TX 77030